For research use only. Not for therapeutic Use.
Apimostinel（Cat No.:I002584）is a novel antidepressant peptide that acts as a partial agonist of the NMDA (N-methyl-D-aspartate) receptor. By modulating this receptor, Apimostinel enhances synaptic plasticity and exerts rapid antidepressant effects, making it a promising candidate for treating major depressive disorder (MDD) and other mood disorders. Unlike traditional antidepressants, Apimostinel provides fast-acting relief with a favorable safety profile, reducing the risk of side effects. Its unique mechanism and potential for rapid symptom improvement position Apimostinel as an innovative approach in the field of psychiatric research and treatment.
| Catalog Number | I002584 |
| CAS Number | 1421866-48-9 |
| Synonyms | (2R)-1-[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-2-benzylpyrrolidine-2-carboxamide |
| Molecular Formula | C25H37N5O6 |
| Purity | ≥95% |
| IUPAC Name | (2R)-1-[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-2-benzylpyrrolidine-2-carboxamide |
| InChI | InChI=1S/C25H37N5O6/c1-15(31)19(26)23(35)29-12-6-10-18(29)22(34)30-13-7-11-25(30,14-17-8-4-3-5-9-17)24(36)28-20(16(2)32)21(27)33/h3-5,8-9,15-16,18-20,31-32H,6-7,10-14,26H2,1-2H3,(H2,27,33)(H,28,36)/t15-,16-,18+,19+,20+,25-/m1/s1 |
| InChIKey | DVBUEXCIEIAXPM-PJUQSVSOSA-N |
| SMILES | CC(C(C(=O)N1CCCC1C(=O)N2CCCC2(CC3=CC=CC=C3)C(=O)NC(C(C)O)C(=O)N)N)O |
